ES2084126T3 - Nuevos derivados de nojirimicina. - Google Patents

Nuevos derivados de nojirimicina.

Info

Publication number
ES2084126T3
ES2084126T3 ES91401096T ES91401096T ES2084126T3 ES 2084126 T3 ES2084126 T3 ES 2084126T3 ES 91401096 T ES91401096 T ES 91401096T ES 91401096 T ES91401096 T ES 91401096T ES 2084126 T3 ES2084126 T3 ES 2084126T3
Authority
ES
Spain
Prior art keywords
nojirimicina
new derivatives
treatment
derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91401096T
Other languages
English (en)
Inventor
Brigitte Lesur
Jean-Bernard Ducep
Charles Danzin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2084126T3 publication Critical patent/ES2084126T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS DERIVADOS-N DE NOJIRIMICINA 1-DEOXI, AL METODO PARA SU PREPARACION Y A SU UTILIZACION EN EL TRATAMIENTO DE DIABETES Y SU USO CONTRA TETRO-VIRUS, PARTICULARMENTE EN EL TRATAMIENTO DEL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA).
ES91401096T 1990-04-27 1991-04-25 Nuevos derivados de nojirimicina. Expired - Lifetime ES2084126T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401169A EP0453692A1 (en) 1990-04-27 1990-04-27 Novel nojirimycin derivatives

Publications (1)

Publication Number Publication Date
ES2084126T3 true ES2084126T3 (es) 1996-05-01

Family

ID=8205706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91401096T Expired - Lifetime ES2084126T3 (es) 1990-04-27 1991-04-25 Nuevos derivados de nojirimicina.

Country Status (20)

Country Link
EP (2) EP0453692A1 (es)
JP (1) JP2968088B2 (es)
KR (1) KR100191051B1 (es)
CN (1) CN1028368C (es)
AR (1) AR248026A1 (es)
AT (1) ATE132153T1 (es)
AU (1) AU632926B2 (es)
CA (1) CA2041331C (es)
DE (1) DE69115750T2 (es)
DK (1) DK0454580T3 (es)
ES (1) ES2084126T3 (es)
FI (1) FI97885C (es)
GR (1) GR3018797T3 (es)
HU (1) HU212496B (es)
IE (1) IE72477B1 (es)
IL (1) IL97975A (es)
NO (1) NO179913C (es)
PT (1) PT97485B (es)
TW (1) TW201302B (es)
ZA (1) ZA912994B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5986230A (en) * 1996-09-13 1999-11-16 Uncle Ben's, Inc. Method and apparatus for sorting product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
GB8705654D0 (en) * 1987-03-10 1987-04-15 Safe Haul Ltd Pneumatic valve
EP0282618A1 (en) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin as an anti-HIV therapeutic
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs

Also Published As

Publication number Publication date
NO179913B (no) 1996-09-30
CA2041331C (en) 2001-08-28
JPH0586072A (ja) 1993-04-06
KR910018390A (ko) 1991-11-30
JP2968088B2 (ja) 1999-10-25
AR248026A1 (es) 1995-05-31
IL97975A (en) 1996-05-14
NO911665D0 (no) 1991-04-26
GR3018797T3 (en) 1996-04-30
CN1028368C (zh) 1995-05-10
TW201302B (es) 1993-03-01
FI912033A (fi) 1991-10-28
HU911430D0 (en) 1991-11-28
HU212496B (en) 1996-07-29
AU7535191A (en) 1991-11-07
KR100191051B1 (ko) 1999-06-15
IE911417A1 (en) 1991-11-06
IE72477B1 (en) 1997-04-23
DK0454580T3 (da) 1996-01-29
EP0453692A1 (en) 1991-10-30
CN1056104A (zh) 1991-11-13
FI912033A0 (fi) 1991-04-26
DE69115750D1 (de) 1996-02-08
FI97885C (fi) 1997-03-10
ATE132153T1 (de) 1996-01-15
NO911665L (no) 1991-10-28
HUT57782A (en) 1991-12-30
ZA912994B (en) 1992-01-29
FI97885B (fi) 1996-11-29
NO179913C (no) 1997-01-08
CA2041331A1 (en) 1991-10-28
EP0454580A3 (en) 1992-04-29
AU632926B2 (en) 1993-01-14
PT97485B (pt) 1998-08-31
IL97975A0 (en) 1992-06-21
PT97485A (pt) 1992-01-31
DE69115750T2 (de) 1996-05-15
EP0454580A2 (en) 1991-10-30
EP0454580B1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
ES2081857T3 (es) Nuevos inhibidores de alpha-glucosidasa.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
NO20002785D0 (no) Adamantanderivater
NO20002786L (no) Adamantanderivater
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
YU10699A (sh) Upotreba glp-1, glp-1 analoga i glp-1 derivata za proizvodnju leka
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
DK485588D0 (da) Doseringsform omfattende hurtig (laege)middellevering efterfulgt af langsom (laege)middellevering
SE9704546D0 (sv) Novel compounds
NO873842L (no) Baerekonstruksjon for kontorpulter, -bord og lignende, ogsaa med flere arbeids/baereflater.
ES2061528T3 (es) Un procedimiento para preparar nuevos derivados de poliamina.
ES2177695T3 (es) Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral.
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
ME00533B (me) Nova primjena derivata taksoida
ES2023681B3 (es) Procedimiento para tratar piezas de trabajo a base de titanio o aleaciones de titanio, como preparacion.
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler
ES2084126T3 (es) Nuevos derivados de nojirimicina.
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
PE20011080A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454580

Country of ref document: ES